Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

European Journal of Pharmacology

Volumn 659, Issue 2-3, 2011, Pages 187-192

  Higley, Amanda E ^a,b   Kiefer, Stephen W ^b   Li, Xia ^a   Gaál, József ^c   Xi, Zheng Xiong ^a   Gardner, Eliot L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c MegaPharma Kft   (Hungary)

Author keywords

Dopamine D3 receptor; Methamphetamine; Reinstatement; Reward; SB 277011A; Self administration

Indexed keywords

DOPAMINE 3 RECEPTOR BLOCKING AGENT; METHAMPHETAMINE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; MOTIVATION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REINFORCEMENT;

ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; MALE; METHAMPHETAMINE; NITRILES; RATS; RECEPTORS, DOPAMINE D3; SELF ADMINISTRATION; TETRAHYDROISOQUINOLINES;

EID: 79955938357     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.046     Document Type: Article

References (57)

1. Arnold, J.M., Roberts, D.C.S., 1997. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol. Biochem. Behav. 57, 441-447.
2. Ashby Jr., C.R., Paul, M., Gardner, E.L., Heidbreder, C.A., Hagan, J.J., 2003. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 48, 154-156. (Pubitemid 36444341)
3. 2 dopamine receptors. Neuropsychopharmacology 28, 1150-1159.
4. Choi, J.-K., Mandeville, J.B., Chen, Y.I., Grundt, P., Sarkar, S.K., Newman, A.H., Jenkins, B.G., 2010. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists. Psychopharmacology 212, 59-72.
5. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28, 329-338.
6. Gal, K., Gyertyan, I., 2003. Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats. Brain Res. Bull. 61, 595-601.
7. Gardner, E.L., 2000. What we have learned about addiction from animal models of drug self-administration. Am. J. Addict. 9, 285-313.
8. Gilbert, J.G., Newman, A.H., Gardner, E.L., Ashby Jr., C.R., Heidbreder, C.A., Pak, A.C., Peng, X.-Q., Xi, Z.-X., 2005. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse 57, 17-28. (Pubitemid 40756331)
9. Heidbreder, C., 2008. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence. CNS Neurol. Disord. Drug Targets 7, 410-421.
10. 3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict. Biol. 12, 35-50.
11. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Rev. 49, 77-105.
12. 3 receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann. N.Y. Acad. Sci. 1187, 4-34.
13. Higley, A.E., Spiller, K., Grundt, P., Newman, A.H., Kiefer, S.W., Xi, Z.-X., Gardner, E.L., 2011. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats. J. Psychopharmacol. 25, 263-273.
14. Hyman, S.E., Malenka, R.C., Nestler, E.J., 2006. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565-598.
15. Jaffe, J.H., Cascella, N.G., Kumor, K.M., Sherer, M.A., 1989. Cocaine-induced cocaine craving. Psychopharmacology 97, 59-64. (Pubitemid 19020384)
16. Kalivas, P.W., Volkow, N.D., 2005. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162, 1403-1413. (Pubitemid 41105554)
17. Khroyan, T.V., Barrett-Larimore, R.L., Rowlett, J.K., Spealman, R.D., 2000. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J. Pharmacol. Exp. Ther. 294, 680-687.
18. Kitamura, O., Wee, S., Specio, S.E., Koob, G.F., Pulvirenti, L., 2006. Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology 186, 48-53. (Pubitemid 43668310)
19. Koob, G.F., Nestler, E.J., 1997. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9, 482-497.
20. Le Foll, B., Goldberg, S.R., Sokoloff, P., 2005. The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49, 525-541.
21. Mendelson, J.H., Mello, N.K., 1996. Management of cocaine abuse and dependence. N. Engl. J. Med. 334, 965-972.
22. National Academy of Sciences, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
23. Newman, A.H., Grundt, P., Nader, M.A., 2005. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J. Med. Chem. 48, 3663-3679.
24. O'Brien, C.P., 1997. A range of research-based pharmacotherapies for addiction. Science 278, 66-70. (Pubitemid 27446273)
25. O'Brien, C.P., Childress, A.R., McLellan, A.T., Ehrman, R., 1992. Classical conditioning in drug-dependent humans. Ann. N.Y. Acad. Sci. 654, 400-415.
26. Orio, L., Wee, S., Newman, A.H., Pulvirenti, L., Koob, G.F., 2010. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict. Biol. 15, 312-323.
27. 3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int. J. Neuropsychopharmacol. 9, 585-602.
28. Pierce, R.C., Kumaresan, V., 2006. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci. Biobehav. Rev. 30, 215-238.
29. Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C.G., Schwartz, J.-C., Everitt, B.J., Sokoloff, P., 1999. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400, 371-375. (Pubitemid 29344203)
30. Rawson, R.A., McCann, M.J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., Ling, W., 2006. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 101, 267-274. (Pubitemid 43351600)
31. 3 receptor antagonist, SB-277011-A. J. Pharmacol. Exp. Ther. 294, 1154-1165.
32. Richardson, N.R., Roberts, D.C.S., 1996. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66, 1-11. (Pubitemid 26180064)
33. Roberts, D.C.S., 1989. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 32, 43-47.
34. Roberts, D.C.S., Loh, E.A., Vickers, G., 1989. Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97, 535-538. (Pubitemid 19102558)
35. Rogers, J.L., De Santis, S., See, R.E., 2008. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 199, 615-624.
36. Rose, M.E., Grant, J.E., 2008. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann. Clin. Psychiatry 20, 145-155.
37. Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Sciences, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD.
38. Schwarz, A., Gozzi, A., Reese, T., Bertani, S., Crestan, V., Hagan, J., Heidbreder, C., Bifone, A., 2004. Selective dopamine D3 receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 54, 1-10. (Pubitemid 39129668)
39. Schwendt, M., Rocha, A., See, R.E., Pacchioni, A.M., McGinty, J.F., Kalivas, P.W., 2009. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J. Pharmacol. Exp. Ther. 331, 555-562.
40. Self, D.W., Barnhart, W.J., Lehman, D.A., Nestler, E.J., 1996. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271, 1586-1589. (Pubitemid 26097217)
41. Shaham, Y., Stewart, J., 1994. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology 114, 523-527. (Pubitemid 24153505)
42. Shalev, A.Y., 2003. The interdisciplinary study of posttraumatic stress disorder. CNS Spectr. 8, 640. (Pubitemid 38418983)
43. Shalev, U., Highfield, D., Yap, J., Shaham, Y., 2000. Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology 150, 337-346. (Pubitemid 30447854)
44. Sinha, R., 2001. How does stress increase risk of drug abuse and relapse? Psychopharmacology 158, 343-359.
45. Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., Schwartz, J.-C., 1990. Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics. Nature 347, 146-151.
46. Spiller, K., Xi, Z.-X., Peng, X.-Q., Newman, A.H., Ashby Jr., C.R., Heidbreder, C., Gaál, J., Gardner, E.L., 2008. The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Psychopharmacology 196, 533-542.
47. Stewart, J., 2000. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatry Neurosci. 25, 125-136. (Pubitemid 30233550)
48. Thanos, P.K., Katana, J.M., Ashby Jr., C.R., Michaelides, M., Gardner, E.L., Heidbreder, C.A., Volkow, N.D., 2005. The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol. Biochem. Behav. 81, 190-197.
49. UNODC, World Drug Report, 2010. United Nations Publication. Sales No. E.10.XI.13.
50. Vorel, S.R., Ashby Jr., C.R., Paul, M., Liu, X., Hayes, R., Hagan, J.J., Middlemiss, D.N., Stemp, G., Gardner, E.L., 2002. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22, 9595-9603. (Pubitemid 35356201)
51. Wee, S., Wang, Z., Woolverton, W.L., Pulvirenti, L., Koob, G.F., 2007. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology 32, 2238-2247. (Pubitemid 47417701)
52. Wise, R.A., 1996. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19, 319-340.
53. Wise, R.A., 2005. Forebrain substrates of reward and motivation. J. Comp. Neurol. 493, 115-121.
54. Xi, Z.-X., Gardner, E.L., 2007. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev. 13, 240-259. (Pubitemid 47052351)
55. 3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 176, 57-65.
56. 3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 21, 3427-3438.
57. Xi, Z.-X., Newman, A.H., Gilbert, J.G., Pak, A.C., Peng, X.-Q., Ashby Jr., C.R., Gitajn, L., Gardner, E.L., 2006. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 31, 1393-1405.